Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin receptor 5-HT2B is a G protein-coupled receptor (GPCR) that primarily signals through the Gq protein, leading to activation of downstream pathways such as phospholipase C and MAPK/ERK. It is expressed in the CNS and PNS, notably in cardiac valve leaflets where it is essential for normal development and maintenance. Overstimulation of this receptor is linked to drug-induced valvular heart disease. It is also implicated in mood disorders such as depression.
Agonists stimulate the receptor leading to Gq protein activation and downstream signaling via phospholipase C and MAPK/ERK pathways. Antagonists block receptor activation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor 5-HT2B (5-HT2B).